筹划中
Pathology Managed Service – Preliminary Market Engagement
Gloucestershire Hospitals NHS Foundation Trust已就“Pathology Managed Service – Preliminary Market Engagement”发布此招标,现已不再接受新的投标。
此招标已不再接受新的投标。 类似的进行中招标
用通俗的话说,这项招标是什么?
此公告尚未翻译,以原文语言显示。
同类招标的过往中标记录说明了什么?
- 同类招标平均每项约有 1.5 份投标(10 项中标记录载有数目)。
- 半数同类合同的中标金额介于 £49,686 至 £382,000,中位数为 £136,000。
- CONSTELLIA LIMITED 在过去三年从该采购方取得 3 份同类合同。
根据过去 36 个月 142 项中标记录:相同工种、相同地区。可信程度:高。以上仅反映过往情况,并非预测结果。 中标数据
谁赢得了这项招标,金额是多少?
此招标尚未公布中标结果。
公告全文
原文(English)
Pathology Managed Service – Preliminary Market Engagement
Gloucestershire Hospitals NHS Foundation Trust (“the Authority”) is undertaking preliminary market engagement ahead of a competitive procurement for a Pathology Managed Service. The intended contract will provide, as a managed service, the laboratory equipment (analytical platforms, automation, point-of-care devices and associated instrumentation), reagents, consumables, maintenance, software/middleware, training and lifecycle replacement required to deliver the Authority’s pathology service.
The service is expected to be structured in two phases: Phase 1 covering the Authority’s existing laboratories at Gloucestershire Royal Hospital and Cheltenham General Hospital, and Phase 2 following consolidation into a new-build pathology hub. The Authority’s working direction is a new-build hub with the location not yet determined; two options remain under consideration, each with implications for the service model that suppliers should allow for:
A hub on the Gloucester (hospital) site would require continued urgent haematology and clinical chemistry provision at Cheltenham General.
An off-site hub would require acute (hot lab) provision and resilience at both Gloucestershire Royal and Cheltenham General. Transfusion provision should not be assumed at all three locations (remote issue, transport, storage, space and staffing remain dependencies); for microbiology, an off-site hub may require on-site blood-culture loading at the acute sites and further review of patient-facing sample collection and cryo/storage services. For cellular pathology, reliable frozen-section transport between sites would be essential.
The disciplines in scope are Blood Sciences (clinical biochemistry, haematology, coagulation, immunology, transfusion-related equipment where included), Infection Sciences (microbiology, virology/molecular) and Cellular Pathology, together with enabling works to prepare laboratory space for installation. The Authority anticipates a lead provider for Blood Sciences with further lots or sub-lots for the other disciplines; the lot structure is a matter on which market feedback is sought.
The Authority is seeking supplier feedback on the draft service specification, draft key performance indicators, the proposed lot structure and phasing, the commercial and pricing model, the evaluation approach and the proposed timetable, in order to finalise its procurement strategy and tender documents. Participation is open to all interested suppliers including SMEs, specialist providers and potential sub-contractors or consortium members.
通过邮件接收这些招标
每天一封邮件,列出你所选行业和地区的新招标。无需账户或密码。
快速解答
这项招标什么时候截止?
公告没有注明截止日期。请查看采购方的门户网站。
这份合同价值多少?
采购方估计金额为£180,000,000。
采购方是谁?
采购方是Gloucestershire Hospitals NHS Foundation Trust。
同类招标通常有多少企业投标?
同类招标平均每项约有 1.5 份投标(10 项中标记录载有数目)。 根据过去 36 个月 142 项中标记录:相同工种、相同地区。可信程度:高。以上仅反映过往情况,并非预测结果。